1
|
Jurczak E, Mazurek AH, Szeleszczuk Ł, Pisklak DM, Zielińska-Pisklak M. Pharmaceutical Hydrates Analysis-Overview of Methods and Recent Advances. Pharmaceutics 2020; 12:pharmaceutics12100959. [PMID: 33050621 PMCID: PMC7601571 DOI: 10.3390/pharmaceutics12100959] [Citation(s) in RCA: 33] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2020] [Revised: 09/26/2020] [Accepted: 10/07/2020] [Indexed: 11/16/2022] Open
Abstract
This review discusses a set of instrumental and computational methods that are used to characterize hydrated forms of APIs (active pharmaceutical ingredients). The focus has been put on highlighting advantages as well as on presenting some limitations of the selected analytical approaches. This has been performed in order to facilitate the choice of an appropriate method depending on the type of the structural feature that is to be analyzed, that is, degree of hydration, crystal structure and dynamics, and (de)hydration kinetics. The presented techniques include X-ray diffraction (single crystal X-ray diffraction (SCXRD), powder X-ray diffraction (PXRD)), spectroscopic (solid state nuclear magnetic resonance spectroscopy (ssNMR), Fourier-transformed infrared spectroscopy (FT-IR), Raman spectroscopy), thermal (differential scanning calorimetry (DSC), thermogravimetric analysis (TGA)), gravimetric (dynamic vapour sorption (DVS)), and computational (molecular mechanics (MM), Quantum Mechanics (QM), molecular dynamics (MD)) methods. Further, the successful applications of the presented methods in the studies of hydrated APIs as well as studies on the excipients' influence on these processes have been described in many examples.
Collapse
Affiliation(s)
- Ewa Jurczak
- Department of Physical Chemistry, Chair and Department of Physical Pharmacy and Bioanalysis, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 str., 02-093 Warsaw, Poland; (E.J.); (A.H.M.); (D.M.P.)
| | - Anna Helena Mazurek
- Department of Physical Chemistry, Chair and Department of Physical Pharmacy and Bioanalysis, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 str., 02-093 Warsaw, Poland; (E.J.); (A.H.M.); (D.M.P.)
| | - Łukasz Szeleszczuk
- Department of Physical Chemistry, Chair and Department of Physical Pharmacy and Bioanalysis, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 str., 02-093 Warsaw, Poland; (E.J.); (A.H.M.); (D.M.P.)
- Correspondence: ; Tel.: +48-501-255-121
| | - Dariusz Maciej Pisklak
- Department of Physical Chemistry, Chair and Department of Physical Pharmacy and Bioanalysis, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 str., 02-093 Warsaw, Poland; (E.J.); (A.H.M.); (D.M.P.)
| | - Monika Zielińska-Pisklak
- Department of Biomaterials Chemistry, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 str., 02-093 Warsaw, Poland;
| |
Collapse
|
2
|
Hong M, Chen J, Zhou H, Xu H, Ren G. Investigation of a solution-mediated phase transformation of pranlukast DMF solvate to hemihydrate. CRYSTAL RESEARCH AND TECHNOLOGY 2017. [DOI: 10.1002/crat.201700045] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Minghuang Hong
- Laboratory of Pharmaceutical Crystal Engineering & Technology; School of Pharmacy; East China University of Science and Technology; 130 Meilong Road Shanghai 200237
| | - Jingyan Chen
- Laboratory of Pharmaceutical Crystal Engineering & Technology; School of Pharmacy; East China University of Science and Technology; 130 Meilong Road Shanghai 200237
| | - Hui Zhou
- Laboratory of Pharmaceutical Crystal Engineering & Technology; School of Pharmacy; East China University of Science and Technology; 130 Meilong Road Shanghai 200237
| | - Hao Xu
- Laboratory of Pharmaceutical Crystal Engineering & Technology; School of Pharmacy; East China University of Science and Technology; 130 Meilong Road Shanghai 200237
| | - Guobin Ren
- Laboratory of Pharmaceutical Crystal Engineering & Technology; School of Pharmacy; East China University of Science and Technology; 130 Meilong Road Shanghai 200237
| |
Collapse
|
3
|
Xiong X, Xu K, Du Q, Zeng X, Xiao Y, Yang H, Li H. Effects of Temperature and Solvent on the Solid-State Transformations of Pranlukast During Mechanical Milling. J Pharm Sci 2017; 106:1680-1687. [PMID: 28249805 DOI: 10.1016/j.xphs.2017.02.020] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2016] [Revised: 02/03/2017] [Accepted: 02/13/2017] [Indexed: 11/16/2022]
Abstract
Four solid forms of pranlukast (PRS) were obtained during mechanical milling including neat milling (NM) and solvent-drop milling (SDM), which were characterized by various analytical techniques. The effect of milling conditions including 3 milling temperatures and 6 assist solvents on the solid-state transformations of commercial PRS (PRS HH) was systemically investigated. Milling temperature significantly influenced the NM process. A low milling temperature (5°C) led to a complete amorphization of PRS HH, whereas higher milling temperatures (15°C and 30°C) only induced a partial amorphization. The milling at 5°C was proven to be a progressive amorphization process, and the amorphous material showed an increasing stability with prolonged milling time. Amorphous PRS can stay stable under low temperature and relative humidity conditions and showed significantly higher solubilities and faster dissolution rates in both water and pH 6.8 phosphate buffer solution. A total of 6 solvents were used in the SDM experiments. N,N-dimethylformamide and dimethyl sulfoxide should be avoided in the manufacturing process of PRS because corresponding solvates of PRS can be easily generated by SDM of PRS HH with short milling time and small amount of solvents.
Collapse
Affiliation(s)
- Xinnuo Xiong
- College of Chemical Engineering, Sichuan University, Chengdu 610065, China
| | - Kailin Xu
- College of Chemical Engineering, Sichuan University, Chengdu 610065, China
| | - Qiaohong Du
- College of Chemical Engineering, Sichuan University, Chengdu 610065, China
| | - Xia Zeng
- College of Chemical Engineering, Sichuan University, Chengdu 610065, China
| | - Ying Xiao
- College of Chemical Engineering, Sichuan University, Chengdu 610065, China
| | - Hongqin Yang
- College of Chemical Engineering, Sichuan University, Chengdu 610065, China
| | - Hui Li
- College of Chemical Engineering, Sichuan University, Chengdu 610065, China.
| |
Collapse
|
4
|
Furuta H, Mori S, Yoshihashi Y, Yonemochi E, Uekusa H, Sugano K, Terada K. Physicochemical and crystal structure analysis of pranlukast pseudo-polymorphs II: Solvate and cocrystal. J Pharm Biomed Anal 2015; 111:44-50. [PMID: 25854856 DOI: 10.1016/j.jpba.2015.03.008] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2015] [Revised: 03/06/2015] [Accepted: 03/09/2015] [Indexed: 11/25/2022]
Abstract
Pranlukast (PRS) is a leukotriene receptor antagonist for the treatment of bronchial asthma. In this study, six new solvates and one new cocrystal of PRS were characterized by PXRD, TG-DTA, DSC, vapor sorption analysis and the dissolution test. In addition, the crystal structures were determined by single crystal X-ray structure analysis. PRS was found to be a rare example of a promiscuous multicomponent crystal former. The crystal packing patterns of these crystals can be categorized into the sheet-like and channel-like patterns. The ethanol solvate (PRS/ethanol) and urea cocrystal (PRS/urea) were more stable than the others under humid conditions. PRS/ethanol showed an improved dissolution profile compared to PRS HH and PRS/urea.
Collapse
Affiliation(s)
- Hideaki Furuta
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Toho University, 2-2-1, Miyama, Funabashi, Chiba 274-8510, Japan
| | - Shintaro Mori
- Graduate School of Science and Engineering, Department of Chemistry and Materials Science, Tokyo Institute of Technology, 12-1-H62, Ookayama 2, Meguro-ku, Tokyo 152-8551, Japan
| | - Yasuo Yoshihashi
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Toho University, 2-2-1, Miyama, Funabashi, Chiba 274-8510, Japan
| | - Etsuo Yonemochi
- School of Pharmacy and Pharmaceutical Sciences, Hoshi University, 2-4-41, Ebara, Shinagawa, Tokyo 142-8501, Japan
| | - Hidehiro Uekusa
- Graduate School of Science and Engineering, Department of Chemistry and Materials Science, Tokyo Institute of Technology, 12-1-H62, Ookayama 2, Meguro-ku, Tokyo 152-8551, Japan
| | - Kiyohiko Sugano
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Toho University, 2-2-1, Miyama, Funabashi, Chiba 274-8510, Japan.
| | - Katsuhide Terada
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Toho University, 2-2-1, Miyama, Funabashi, Chiba 274-8510, Japan
| |
Collapse
|